Searched over 200M research papers for "essential hypertension"
10 papers analyzed
These studies suggest that essential hypertension is a complex, multifactorial condition influenced by genetic, environmental, and epigenetic factors, requiring individualized treatment to manage its complications and reduce risks of cardiovascular and cognitive issues.
20 papers analyzed
Essential hypertension is a chronic condition characterized by persistently elevated blood pressure (BP) with no identifiable secondary cause. It is a major modifiable risk factor for cardiovascular diseases (CVD), including stroke, myocardial infarction, and heart failure, affecting millions globally. Despite advances in treatment, the prevalence of essential hypertension continues to rise, contributing significantly to the global burden of CVD and renal diseases .
Essential hypertension is a complex, polygenic disorder influenced by multiple genetic factors. Research indicates that while monogenic forms of hypertension exist, most cases arise from the interaction of numerous genes, each contributing modestly to the overall risk . The Human Genome Project and ongoing genetic studies aim to identify these susceptibility genes, which could lead to more targeted and effective treatments .
Environmental factors such as diet, physical activity, and stress play a crucial role in the development of essential hypertension. Additionally, epigenetic modifications—heritable changes in gene expression without alterations in the DNA sequence—are increasingly recognized as significant contributors. These include DNA methylation, histone modifications, and the influence of non-coding RNAs, which together modulate the risk of developing hypertension .
The pathophysiology of essential hypertension involves the kidneys' inability to excrete sodium efficiently, leading to increased blood volume and pressure. The central nervous system, endocrine factors, and both large and small arteries also play critical roles in maintaining elevated BP.
Recent studies suggest that the brain is not only a target of hypertensive damage but also plays a role in the initiation of high BP. Neural control of the vasculature and kidneys, cognitive deficits, and altered cerebral blood flow are associated with early-stage hypertension. These changes can lead to structural and functional brain alterations, which are not fully reversible with pharmacological treatment.
Antihypertensive medications are the cornerstone of hypertension management, significantly reducing the risk of CVD and renal complications. However, the effectiveness of these treatments can vary based on genetic and environmental factors, highlighting the need for personalized medicine approaches .
Lifestyle modifications, including dietary changes, increased physical activity, and stress management, are essential components of hypertension management. These strategies can effectively lower BP and reduce the need for medication in some individuals.
Essential hypertension is a multifaceted condition influenced by genetic, environmental, and epigenetic factors. Understanding its complex etiology and pathophysiology is crucial for developing effective treatment strategies. Ongoing research into the genetic and epigenetic underpinnings of hypertension holds promise for more personalized and targeted therapeutic approaches, potentially revolutionizing the management of this pervasive condition.
Most relevant research papers on this topic